- Home
- SNGX vs SEED Comparison
SNGX vs SEED Comparison
Compare SNGX & SEED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNGX
- SEED
- Stock Information
- Founded
- SNGX 1987
- SEED 1997
- Country
- SNGX United States
- SEED China
- Employees
- SNGX N/A
- SEED N/A
- Industry
- SNGX Biotechnology: Pharmaceutical Preparations
- SEED Farming/Seeds/Milling
- Sector
- SNGX Health Care
- SEED Consumer Staples
- Exchange
- SNGX Nasdaq
- SEED Nasdaq
- Market Cap
- SNGX 6.5M
- SEED 7.5M
- IPO Year
- SNGX 1987
- SEED N/A
- Fundamental
- Price
- SNGX $1.28
- SEED $0.95
- Analyst Decision
- SNGX
- SEED
- Analyst Count
- SNGX 0
- SEED 0
- Target Price
- SNGX N/A
- SEED N/A
- AVG Volume (30 Days)
- SNGX 2.7M
- SEED 75.9K
- Earning Date
- SNGX 08-08-2025
- SEED 06-26-2025
- Dividend Yield
- SNGX N/A
- SEED N/A
- EPS Growth
- SNGX N/A
- SEED N/A
- EPS
- SNGX N/A
- SEED N/A
- Revenue
- SNGX $2,342.00
- SEED $12,910,081.00
- Revenue This Year
- SNGX N/A
- SEED N/A
- Revenue Next Year
- SNGX N/A
- SEED N/A
- P/E Ratio
- SNGX N/A
- SEED N/A
- Revenue Growth
- SNGX N/A
- SEED N/A
- 52 Week Low
- SNGX $1.09
- SEED $0.95
- 52 Week High
- SNGX $14.83
- SEED $4.86
- Technical
- Relative Strength Index (RSI)
- SNGX 34.08
- SEED 43.38
- Support Level
- SNGX $1.09
- SEED $0.95
- Resistance Level
- SNGX $1.29
- SEED $1.61
- Average True Range (ATR)
- SNGX 0.13
- SEED 0.11
- MACD
- SNGX -0.02
- SEED -0.01
- Stochastic Oscillator
- SNGX 22.15
- SEED 12.00
About SNGX Soligenix Inc.
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).
About SEED Origin Agritech Limited
Origin Agritech Ltd is a Chinese agricultural technology company operating in the PRC including seed research and development activities featured in crop seed breeding and genetic improvement. The company's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Origin has established a robust biotechnology seed pipeline including products with glyphosate tolerance and pest resistance (Bt) traits.